[1] 王国华, 申东升, 熊维. 抗凝血新药利伐沙班[J].中国新药杂志, 2009, 18(6):494-496.
[2] Lassen M R, Ageno W, Borris L C, et al..Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty[J]. N Engl J Med, 2008, 358(26):2776-2786.
[3] Turpie A, BauerK, Davidson B, et al. Comparison of rivaroxaban-an oral, direct factor Xa inhibitor-and subcutaneous enoxa- parin for thromboprophylaxis after total knee replacement[R].European Federation of National Associations of Orthopaedics and Traumatology.Annual Meeting. 2008-05-29. France. Abstract F85. |
